Zheng et al. [13] reported significant correlations between AIP, homeostatic model assessment of insulin resistance (HOMA-IR), and inflammatory markers such as C-reactive protein, further supporting its role as a comprehensive metabolic risk marker. The gene discussed is CRP; the disease is Insulin resistance.